chrisvoncsefalvay/vaers-outcomes huggingface dataset:
some issues with nerves and she couldnt see anything; Bad pain on neck and arm; numbness and tingling in toes and fingers; pain is still bad; weaker fingers, numbness and joint pain till today; bad pain on neck and arm; numbness and tingling in toes and fingers; lost her appetite; Left eye swelled few hours after taking shot; Some issues with nerves and she couldn't see anything; intense pressure headache; nausea; Neck muscles seized up; lump on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (intense pressure headache), NAUSEA (nausea), MUSCLE TIGHTNESS (Neck muscles seized up), NEURALGIA (some issues with nerves and she couldnt see anything) and VISUAL IMPAIRMENT (Some issues with nerves and she couldn't see anything) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006c21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced HEADACHE (intense pressure headache), NAUSEA (nausea), MUSCLE TIGHTNESS (Neck muscles seized up), VISUAL IMPAIRMENT (Some issues with nerves and she couldn't see anything), EYE SWELLING (Left eye swelled few hours after taking shot) and VACCINATION SITE MASS (lump on the injection site). On 22-Apr-2021, the patient experienced DECREASED APPETITE (lost her appetite), NECK PAIN (bad pain on neck and arm) and HYPOAESTHESIA (numbness and tingling in toes and fingers). On an unknown date, the patient experienced NEURALGIA (some issues with nerves and she couldnt see anything), VACCINATION SITE PAIN (Bad pain on neck and arm), PARAESTHESIA (numbness and tingling in toes and fingers), PAIN (pain is still bad) and ARTHRALGIA (weaker fingers, numbness and joint pain till today). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Headache, at a dose of 1 dosage form; DIPHENHYDRAMINE HYDROCHLORIDE (ANTIHISTAMINE ALLERGY RELIEF) for Eye swelling, at a dose of 1 dosage form and IBUPROFEN for Pain, at a dose of 1 dosage form. At the time of the report, HEADACHE (intense pressure headache), NAUSEA (nausea), MUSCLE TIGHTNESS (Neck muscles seized up), NEURALGIA (some issues with nerves and she couldnt see anything), VISUAL IMPAIRMENT (Some issues with nerves and she couldn't see anything), DECREASED APPETITE (lost her appetite), EYE SWELLING (Left eye swelled few hours after taking shot), NECK PAIN (bad pain on neck and arm), VACCINATION SITE PAIN (Bad pain on neck and arm), HYPOAESTHESIA (numbness and tingling in toes and fingers), PARAESTHESIA (numbness and tingling in toes and fingers), PAIN (pain is still bad), VACCINATION SITE MASS (lump on the injection site) and ARTHRALGIA (weaker fingers, numbness and joint pain till today) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The Concomitant medications were not provided.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE NON ST ELEVATION MI ALLERGIC REACTION, SUBSEQ 3/13/2023 -- RECURRENCE OF SAME SYMPTOMS
Received VARIVAX (L) arm 2/14 - local swelling started the following day. I saw him 2/19. Lesion was resolving/itchy. No systemic symptoms.
This spontaneous report was received from a consumer, reporting on herself who on 13-MAR-2012, was vaccinated with a dose of ZOSTAVAX (dose, route and lot number not reported). No other co-suspects were reported. No concomitant medications were reported. The consumer reported that on an unknown date, she experienced the shingles after receiving the vaccine. No treatment information was reported. At the time of the report, the patient's outcome was unknown. The relatedness for patient experienced shingles was unknown for ZOSTAVAX. This is one of several reports from the same source. Additional information has been requested.
rash - red and inflamed. began on upper arms and within 24 hours of emerging continued onto legs, tops of feet ,all the way down both arms. There was NOT a concentrated rash on or around the left arm injection site.  All rash was on "top" of body, with little exception aside from lower calves which migrated toward the back, but did not encircle the leg. Rash began to subside and was present but fading within 48 hours when I experienced a secondary flare in the same area, and a patch on my hip (where the trunk had otherwise been spared). These again became less "angry" within 24 hours. Today, the rash is visible but muted. Rash responds well to cortisol cream. For history, I had hives only once after receiving antibiotics (15 years ago). I don't have any known food allergies. I don't have any skin disorder (e.g., psoriasis, eczema) and have never had a contract dermatitis. In other words, I have not historically shown a propensity for skin response to allergens.
It (Covid-19 vaccine) had an expiration date of 19Aug2021; Swelling of injection site; Petechiae; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP and Physician) from medical information team for a Pfizer sponsored program (005570). The reporter is the parent. Other Case identifier(s): US-PFIZER INC-202101843260 (Pfizer).  A 6 year-old female patient received bnt162b2 (BNT162B2), administered in arm right, administration date 21Dec2021 (Lot number: 5K5127, Expiration Date: 19Aug2021) at the age of 6 years as dose 2 (tris), single for covid-19 immunisation. Relevant medical history included: "Hypothyroidism" (ongoing), notes: Diagnosed about a year ago; "GERD" (ongoing), notes: Diagnosed at birth; "Bernard-Soulier syndrome" (ongoing), notes: States this is the bleeding disorder, which is part of the 22q11.2, Diagnosed probably about 4 years ago when patient had major bleed; "Thrombocytopenia" (ongoing), notes: Part of 22q11.2 , Diagnosed at birth; "22q11.2" (ongoing), notes: DiGeorge Syndrome Velocardiofacial Syndrome, 22q11.2 deletion conception; "Heart issues" (unspecified if ongoing), notes: Caller can't remember what they are Part of 22q11.2; "Has only one kidney" (unspecified if ongoing), notes: Part of 22q11.2; "Immunocompromised" (unspecified if ongoing), notes: She notes that her daughter has a bleeding disorder and is immunocompromised.; "Chronic Epistaxis" (ongoing), notes: birth; "ADHD" (unspecified if ongoing). Concomitant medication(s) included: FLU taken for immunisation, start date: Nov2021, stop date: Nov2021; IVIGLOB-EX; GUANFACINE taken for attention deficit hyperactivity disorder (ongoing). Vaccination history included: Bnt162b2 (Dose 1, LOT: FK5618, Route: Right upper arm), administration date: 29Nov2021, when the patient was 6 years old, for Covid-19 Immunization. The following information was reported: EXPIRED PRODUCT ADMINISTERED (non-serious) with onset 21Dec2021, outcome "unknown", described as "It (Covid-19 vaccine) had an expiration date of 19Aug2021"; VACCINATION SITE SWELLING (non-serious) with onset 21Dec2021, outcome "not recovered", described as "Swelling of injection site"; PETECHIAE (non-serious) with onset Dec2021, outcome "unknown", described as "Petechiae". Therapeutic measures were not taken as a result of vaccination site swelling, petechiae.  Additional information: Caller asked the pharmacist to look at the dose and the amount the patient was being given. Caller wanted to see the bottle and saw the expiry on the bottle was 19Aug2021. Caller stated that was expired. Pharmacist clarified saying no, the expiry has been extended and he would not administer the patient a dose if that expiry extension was not approved. Caller states her 6 y/o daughter received her first pediatric Pfizer Covid vaccine dose on 29Nov2021 and second dose on 21Dec2021. Within 5 minutes her injection site became swollen and she know has petechiae in the area. She notes that her daughter has a bleeding disorder and is immunocompromised.   No follow-up attempts are possible. No further information is expected.
Patient states that she felt fine after the vaccine was administered at ~6:10pm on 1/6/20.  She went home and states that symptoms began around 2:00am 1/7/20.  States that at this time she experienced arm pain and inflammation.  She said that basically the entire arm was hurting from shoulder to fingers.  States that swelling was present as well.  Patient also says that her temperature was 100 degrees Fahrenheit and that she was experiencing general weakness.
Approximately 12 hours after the shot, began having terrible anxiety and electrical pulses through my nerves. Since then have had headaches on and off, muscle knots and pain in muscles. All of these are typically what I experience when I'm having bouts of fibromyalgia as well as having an anxiety disorder that it has seemed to set off. I am going on 5th day of this.
Patient got her COVID vaccine on April 22. This was the Moderna vaccine. About 4 days after the shot, she was still having a lot of arm soreness, some numbness and tingling, which goes down through the arm and into the whole hand. Feels always like she has just slept on the arm. She is having some difficulty lifting the arm and can only get it to about just above 90 degrees. Otherwise, she feels well. There has not been any redness, fever, or sign of infection. Left upper extremity: On exam she is quite tender in several places on the arm, primarily along the trapezius on her left side down along the supraspinous at the AC joint. Some of the deltoid bursa does lay very tender anteriorly and posteriorly over the shoulder joint. I am able to lift the arm, but she is very resistant to going up above that 90-degree point. Her internal-external rotation were good when she had the arm resting at her side, but she really was not able to do  any of that when she would try to lift the arm. Arm soreness with some limitation of motion. We will send a CBC, sedimentation rate, and CRP to make sure there is not any infection in the arm joint. Certainly, clinically that seems  quite, unlikely. I suspect this is just a prolonged reaction to the vaccine. She may be getting set up for a frozen shoulder, so if her lab work looks good. we will refer her for some physical therapy. While technically it is probably still fine to repeat the 2nd dose of the vaccine, I am not sure I can in good faith recommend that she do that, so I will discuss that with her as soon as her lab work is available.
I was given a flu shot too high in my right shoulder joint instead of in the deltoid muscle. I had severe pain in the right shoulder for 3-4 months and continued mild pain for 8 months despite NSAIDS.
extreme fatigue; cramping for a couple of days; diarrhea; early period that's been much heavier and longerthan usual; early period that's been much heavier and longerthan usual; early period that's been much heavier and longerthan usual; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 11May2021 at 14:45 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies to medications, food or other products. Concomitant medications included ethinylestradiol, norethisterone acetate (MICROGESTIN) and escitalopram oxalate (ESCITALOPRAM). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021, the patient experienced extreme fatigue along with cramping for a couple of days, diarrhoea then an early period that's been much heavier and longer than usual. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events extreme fatigue, cramping for a couple of days, diarrhoea, early period that's been much heavier and longer were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
PT was given Pneumovax this morning and several hrs later had convulsions (short-lived) and mother bought her back to MD's office where she had fever of 103.4 deg (rectally) and was appearing to be back at baseline.
Two hours after vaccine she had burning and tingling in her mouth and throat, followed by hoarseness, watery; itchy eyes that became "blood shot".  Fever as high as 103.1, cough and body aches. Temperature was back to normal by 10/31/11 but itchy eyes and slight cough persist.
Patient complained on 10/28/17 of a sharp sting in her immunization arm that has been there since the shot was given on 9/13/17. No redness or irritation.
Pain and swelling directly under injection spot, pain and swelling in underarm/lymph node of left arm, slight tingling through to fingers in left arm, occasional numbness through to fingers in left arm
21 FEB 21 SUN: Mild symptoms. Left shoulder pain.  General malaise, Myalgia, Weakness, Headache. Light sensitivity. Loss of appetite. 22 FEB 21 MON:  Severe symptoms. Malaise, Myalgia, Weakness, Headache. Light sensitivity. Loss of appetite. Tremor.  Mental fog and confusion. Inability to think clearly. Impaired situational awareness.  Mostly bedrest.   23 FEB 21 TUE:  Symptoms beginning to resolve.  Malaise, Myalgia, Weakness, Headache. Light sensitivity. Loss of appetite. Tremor.  Mental fog and confusion. Inability to think clearly. Impaired situational awareness.  Up and moving around but did not return to work. 24 FEB WED: Symptoms mostly resolved.  Returned to telework.
feel warm; chills; body is weak; stomach is upset.; This case was reported by a consumer via (Shingrix GSK) interactive digital media and described the occurrence of feeling of warmth in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 12th December 2021, the patient received the 1st dose of Shingles vaccine. On 12th December 2021, less than a day after receiving Shingles vaccine, the patient experienced feeling of warmth, chills, weakness and upset stomach. On an unknown date, the outcome of the feeling of warmth, chills, weakness and upset stomach were unknown.   It was unknown if the reporter considered the feeling of warmth, chills, weakness and upset stomach to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient stated that he/she received Shingles first dose today (on the day of reporting) and felt warm, had chills, his/her body was weak and stomach was upset. The follow-up would not be possible as no contact details were available.
He started to complain that his legs hurt. He received the vaccine in his arms He was very fatigued and laid down at home. Mom was concerned that he was more tired than normal. He started shaking and mom stated he had a temp of 100.4F. He then continued to be very fatigued. According to mom he seemed to be very limp. His heart started racing and he started breathing very fast. Mom became concerned and started to take him to the Emergency Room. On the way to the Emergency Room, mom called 911 because she was concerned that he was starting to lose consciousness. On arrival to the ED, EMS reported that he was tachycardic and complaining of abdominal pain and headache. It is noted in the ED note that he had been taking FLOVENT for a cough he had for 3 weeks. Parents told the ED doctors that he had a cough and congestion for the past 1 week prior to the vaccine. His vitals in the ED were Temp 100.9F, HR 150, RR 20 BP 110/61. He was given a NS bolus, albuterol nebulizer and acetaminophen. He was well appearing to the ED physicians and was dx with a viral URI. He did have lab work done at the parental request: Hematology LATEST RESULTS HISTORICAL RESULTS: WBC 01/14/17 14:38  12.2 12/27/16  10.4 RBC  01/14/17 14:38 5.17 High 12/27/16 5.12  High HGB  01/14/17 14:38  12.8   12/27/16  12.6 HCT 01/14/17 14:38  39.1 12/27/16  38.7 MCV  01/14/17 14:38 76 12/27/16 76 MCH  01/14/17 14:38  24.8  12/27/16  24.6 MCHC  01/14/17 14:38 32.7 12/27/16  32.6 Platelet  01/14/17 14:38  275  12/27/16  301 MPV  01/14/17 14:38  8.6 Low  12/27/16  9.2 RDW-SD  01/14/17 14:38 38.3  12/27/16 37.0 RDW-CV  01/14/17 14:38  13.7   12/27/16  13.4 Abs Neut Ct  01/14/17 14:38   9.55  High   12/27/16  5.10 Abs Immature Gran Ct  01/14/17 14:38  0.03   12/27/16  0.02 Abs Lymph Ct  01/14/17 14:38   1.43  Low   12/27/16  3.98 Abs Mono Ct  01/14/17 14:38  1.11 High 12/27/16  1.04  High Abs Eos  01/14/17 14:38  0.03 12/27/16  0.23 Abs Baso Ct  01/14/17 14:38  0.02 12/27/16  0.05 Mature Neutrophils  01/14/17 14:38  78   12/27/16  49 Immature Gran  01/14/17 14:38  0.2 12/27/16  0.2 Lymphocytes - Normal  01/14/17 14:38  12 12/27/16  38 Monocyte  01/14/17 14:38  9  12/27/16 10 Eosinophil  01/14/17 14:38  0  12/27/16  2 Basophils  01/14/17 14:38 0 12/27/16  0 Sed Rate  01/14/17 14:38  11  High Electrolytes  LATEST RESULTS BUN  01/14/17 14:38 12 Creatinine  01/14/17 14:38 0.30 Low Sodium  01/14/17 14:38  135  Low  Potassium  01/14/17 14 He was discharged to home. He followed up in our office 2 days later and was doing well. He continued to have cough.
Covid; Covid; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old male patient received BNT162b2 (BNT162B2), on 28Apr2022 as dose 4 (booster), single (Lot number: FL59893) at the age of 52 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset May2022, outcome "unknown" and all described as "Covid". Therapeutic measures were taken as a result of covid-19, drug ineffective and treatment with Paxlovid. It was also reported that 5 days of Paxlovid treatment, patient  was really feeling much better. A day after he stopped, started to feel sick again and Covid seemed to get worse. It's now a week since he finished the full Paxlovid treatment and he still have a runny nose, head congestion, diarrhea, sneezing, and coughing. This seems to be the "rebound" effect the media described No follow-up attempts are possible. No further information is expected.
Persistent tinnitus starting 2 hours after vaccination.; ear fullness; Head pressure; Paraesthesia in fingers, toes and thigh; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38 year-old female patient (not pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm left, administration date 12Apr2021 14:30 (Lot number: ER8729) at the age of 38 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "Mild seasonal allergies" (unspecified if ongoing). There were no concomitant medications. The following information was reported: TINNITUS (non-serious) with onset 12Apr2021 16:30, outcome "not recovered", described as "Persistent tinnitus starting 2 hours after vaccination."; EAR DISCOMFORT (non-serious) with onset 12Apr2021 15:00, outcome "not recovered", described as "ear fullness"; HEAD DISCOMFORT (non-serious) with onset 12Apr2021 15:00, outcome "not recovered", described as "Head pressure"; PARAESTHESIA (non-serious) with onset 12Apr2021 15:00, outcome "not recovered", described as "Paraesthesia in fingers, toes and thigh". The events "persistent tinnitus starting 2 hours after vaccination.", "ear fullness", "head pressure" and "paraesthesia in fingers, toes and thigh" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of tinnitus, ear discomfort, head discomfort, paraesthesia.  Additional information: The patient was not pregnant at time of vaccination. The patient had no allergies to medications, food or other products. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. The patient did not receive any other vaccines within 4 weeks prior to COVID-19 vaccine. The vaccine was administered in Pharmacy or Drug Store. Clinical course: Tinnitus lasting 3+ weeks (not resolved) favoring the right ear sometimes accompanied by ear fullness/head pressure. Paraesthesia in fingers, toes and thigh.   No follow-up attempts are possible. No further information is expected.
pt recv vax 22AUG95 & in early DEC95 pt exp chicken pox w/approx 10 scabbing, red lesions & itching;
My son's whole body was shaking. He would not sleep. He was gasping for air. He wouldn't eat and when he did he spit it back up. When I went back to Dr. he told me it wasn't possible for the vaccine to have any adverse effects on my son. I called him a liar and now he sees a new pediatrician. I don't have my records in front of me but I know it was done in June of this year.  9/16/09 PCP records received DOS 6/8-6/16/2009. Assessment: GERD. Milk protein intolerance. Patient presents with papular rash on face, chest. Fussy, not sleeping much, crying. Spits up.
Moderna Covid-19 vaccine was initially stored in the refrigerator on 09-Mar-2022 and expired on 01-Apr-2022; Patient received an expired COVID-19 vaccine as a 2nd Booster dose; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired COVID-19 vaccine as a 2nd Booster dose) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine was initially stored in the refrigerator on 09-Mar-2022 and expired on 01-Apr-2022) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L21B and 048F21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 04-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired COVID-19 vaccine as a 2nd Booster dose). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine was initially stored in the refrigerator on 09-Mar-2022 and expired on 01-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received an expired COVID-19 vaccine as a 2nd Booster dose) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine was initially stored in the refrigerator on 09-Mar-2022 and expired on 01-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  The vial was initially stored in the refrigerator on 09 March 2022. The vial did not undergo any temperature excursions. Patient did not experienced any symptoms post administration of expired vaccine.  No treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Apr-2022: The follow up received contains no new information. On 04-Apr-2022: The follow up received contains no new information. On 05-Apr-2022: The follow up received contains the date of vial was initially stored in the refrigerator updated.